Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-002349-30Phase 4Completed
Phase 4, randomised, double-blind trial of codeine + guaifenesin (2 arms), sponsored by Targid. Primary endpoint: Pharyngeal and esophageal motility patterns. Started Jun 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-002349-30.